TKT and prostate carcinoma: The effectiveness of TK gene delivery in the prostate cancer and bone stromal cell lines was determined using the TK enzymatic activity assay after exposing these cells to Ad-522E-TK and normalized to the external control Ad-CMV-TK for viral infectivity.